<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02070146</url>
  </required_header>
  <id_info>
    <org_study_id>12-510</org_study_id>
    <nct_id>NCT02070146</nct_id>
  </id_info>
  <brief_title>Prospective Data Collection Initiative on Colorectal Cancer</brief_title>
  <acronym>PLCRC</acronym>
  <official_title>Prospective Data Collection Initiative on Colorectal Cancer - a Prospective Observational Cohort Study -</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dutch Colorectal Cancer Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dutch Colorectal Cancer Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Survival after colorectal cancer (CRC) diagnosis strongly depends on local tumor extent,
      lymph node involvement and the presence of distant metastases. However, there remains great
      inter-patient variability regarding treatment outcome. A combination of biochemical factors,
      histopathological features, genomic profile, environmental factors and other clinical factors
      are likely to influence prognosis and treatment effect, independent from tumor stage, but it
      is still unclear which, how, and to what extent these factors can influence tumor recurrence
      and mortality in both early stage (I-III) and late stage (IV) CRC.

      Although the results from prospective clinical trials will remain the backbone of evidence
      based medicine, this concerns a highly selected patient population since the large majority
      (85%-95%) of cancer patients do not participate in clinical trials for various reasons. It is
      unlikely that trial participation will significantly improve in the near future. This fact
      has the following implications: 1) It is highly desirable to validate the results from trials
      in the general patient population. However, this is complicated by the fact that the
      documentation of patients treated in general practice (i.e. outside the scope of clinical
      trials) is largely insufficient to provide comparable patient cohorts in terms of prognostic
      characteristics and treatment parameters. 2) There is an increased availability of novel
      technologies that provide molecular markers with potential prognostic and/or predictive
      value. To test the clinical value of these markers large numbers of patients are required
      which greatly exceeds the number of patients who consent to participate in prospective
      clinical trials. 3) as a result of rapid technical developments, a range of new minimally
      invasive treatment options for CRC are entering the market. These interventions have the
      potential to be of great benefit for patients in terms of improved local control, higher
      probability of complete tumor removal, less damage to surrounding tissue, faster recovery and
      less short and long term side effects. Still, the interventions will have to prove their
      effectiveness, safety and superiority (or non-inferiority) to standard cancer treatments on a
      patient level. A prospective observational cohort study has the great opportunity to fill
      this gap.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives

        -  To start a prospective observational cohort study of CRC patients from their primary
           diagnosis until death.

        -  After obtaining Informed Consent, to prospectively collect data on medical history,
           serious comorbidities, baseline clinical parameters, imaging results, pathology results,
           tumor characteristics, treatment, treatment outcomes, hospital stays, interventions and
           grade 3/4 adverse events.

        -  After obtaining separate Informed Consent for biobanking, to store blood and tumor
           tissue material, obtained during routine practice, in the biobank.

        -  The cohort will serve as an infrastructure geared towards efficient, safe and
           comprehensive clinical evaluation of new (image guided) interventions for treatment of
           CRC.

      Expected outcome

        -  More accurate data on the treatment and clinical and patient reported outcomes of CRC in
           daily practice.

        -  A continuous infrastructure for a large variety of research purposes including:

      A. Prognostic research B. Biological research and (epi)genetic research C. Studies that
      compare new therapies in a target population according to the cohort multiple randomized
      controlled trial design. D. Health care policies and cost-effectiveness studies
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">January 2051</completion_date>
  <primary_completion_date type="Anticipated">January 2050</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>50 Years</target_duration>
  <primary_outcome>
    <measure>Progression free survival</measure>
    <time_frame>up to 10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>3, 6, 12, 24, 36, 48 months</time_frame>
    <description>measured by EORTC QLQ questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grade 3/4 (serious) adverse events</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>up to 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>up to 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work Ability Index (WAI)</measure>
    <time_frame>3, 6, 12, 24, 36, 48 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Colorectal Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and tumor tissue will be stored.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients diagnosed with CRC who are treated in one of the participating hospitals will
        be asked to participate in this cohort study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18 years

          -  Histological proof of CRC

          -  New diagnosis of CRC and/or currently being treated for CRC

        Exclusion Criteria:

          -  None. Participation of patients to the PLCRC project does not exclude participation in
             any other ongoing or future study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miriam Koopman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lenny HM Verkooijen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martijn GH van Oijen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AIDS Malignancy Consortium</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter D Siersema, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miriam Koopman, MD, PhD</last_name>
    <email>m.koopman-6@umcutrecht.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Noordwest Ziekenhuisgroep</name>
      <address>
        <city>Alkmaar</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M.P. Hendriks</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Flevoziekenhuis</name>
      <address>
        <city>Almere</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>D. Sommeijer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Meander Medisch Centrum</name>
      <address>
        <city>Amersfoort</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H. Bloemendal</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AMC</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>C.J.A. Punt</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Antoni van Leeuwenhoek</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G.L Beets</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>OLVG</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>F.O. The</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>VUmc</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M.R. Meijerink</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rijnstate</name>
      <address>
        <city>Arnhem</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>T. van Voorthuizen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wilhelmina Ziekenhuis Assen</name>
      <address>
        <city>Assen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P. Nieboer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rode Kruis Ziekenhuis</name>
      <address>
        <city>Beverwijk</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R.C. Rietbroek</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amphia</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A.J. ten Tije</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>IJsselland Ziekenhuis</name>
      <address>
        <city>Capelle aan den IJssel</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Vermaas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Reinier de Graaf</name>
      <address>
        <city>Delft</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J.W.T. Dekker</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HaaglandenMC</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H.H. Helgason</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HagaZiekenhuis</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P. Quarles van Ufford-Mannesse</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Deventer Ziekenhuizen</name>
      <address>
        <city>Deventer</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. de Noo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albert Schweitzer Ziekenhuis</name>
      <address>
        <city>Dordrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>E.J.Th. Belt</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>I.H.J.T. de Hingh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Admiraal De Ruyter Ziekenhuis</name>
      <address>
        <city>Goes</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Jansen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spaarne Gasthuis</name>
      <address>
        <city>Haarlem</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H.B.A.C. Stockmann</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ziekenhuisgroep Twente</name>
      <address>
        <city>Hengelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. Hoekstra</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tergooi</name>
      <address>
        <city>Hilversum</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A. van der Velden</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Treant</name>
      <address>
        <city>Hoogeveen/Emmen/Stadskanaal</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W.W.H. Roeloffzen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leids Universitair Medisch Centrum</name>
      <address>
        <city>Leiden</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Burgmans</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maastricht UMC+</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. de Vos-Geelen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MAASTRO</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. BerbÃ©e</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Antonius ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Los</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radboudmuc</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>P. vd Boezem</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bravis ziekenhuis</name>
      <address>
        <city>Roosendaal</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>F. Terheggen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus MC</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J.N.M. IJzermans, prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Franciscus Gasthuis &amp; Vlietland</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>F.H. Beverdam</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ikazia Ziekenhuis</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W. de Vles</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maasstad Ziekenhuis</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P.P.L.O Coene</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zuyderland Medisch Centrum</name>
      <address>
        <city>Sittard</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>F. Erdkamp</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Antonius Ziekenhuis</name>
      <address>
        <city>Sneek</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H. van Cruijsen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Rivierenland</name>
      <address>
        <city>Tiel</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Tjin-A-Ton</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elisabeth-TweeSteden Ziekenhuis</name>
      <address>
        <city>Tilburg</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Heisterkamp</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Diakonessenhuis</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A. Schiphorst</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMC Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Koopman, MD, PhD</last_name>
      <email>m.koopman-6@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Miriam Koopman, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lenny HM Verkooijen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VieCuri Medisch Centrum</name>
      <address>
        <city>Venlo</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>F.J. Vogelaar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Jans Gasthuis</name>
      <address>
        <city>Weert</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>N.A.J.B. Peters</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Isala</name>
      <address>
        <city>Zwolle</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J.W. de Groot</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2013</study_first_submitted>
  <study_first_submitted_qc>February 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2014</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

